Results 11 to 20 of about 56,705 (212)
Anesthetic management for cesarean delivery in a Guillain-Barré syndrome patient -A case report- [PDF]
Guillain-Barré syndrome is an acute inflammatory demyelinating polyradiculopathy characterized by progressive motor weakness, areflexia, and ascending paralysis. Guillain-Barré syndrome is extremely rare in pregnant patients, and there are no established
Hyunbin Kim +3 more
doaj +3 more sources
Patient Outcomes Among Medicare Beneficiaries With Guillain-Barré Syndrome. [PDF]
ABSTRACT Background and Aims Understanding of population‐level outcomes for patients with Guillain–Barré syndrome (GBS) remains limited. We identified which GBS patients are most likely to experience worse outcomes using the largest and most current GBS cohort in the United States.
Wright B +5 more
europepmc +2 more sources
Reversible stress cardiomyopathy in Guillain-Barré syndrome: a case report
Background Guillain-Barré syndrome is an autoimmune disorder in which autoantibodies mainly affect the peripheral nervous system. Autonomic dysfunction is a common and severe complication of Guillain-Barré syndrome.
A. Gravos +9 more
doaj +1 more source
Concomitant Guillain–Barré Syndrome in a young Sri Lankan male with severe ulcerative colitis
Background Guillain–Barré Syndrome is an immune mediated polyneuropathy. Ulcerative Colitis is an immune mediated chronic inflammatory condition mainly of the large intestine. Guillain–Barré Syndrome can present as a rare extraintestinal manifestation of
Jayasundara Mudiyanselage Hishali Dahami Jayasundara +4 more
doaj +1 more source
Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS [PDF]
Treatment of Guillain-Barré syndrome with a standard course of high-dose intravenous immunoglobulin (IVIg) results in a variable clinical recovery which is associated with changes in serum IgG levels after treatment. The neonatal Fc-receptor protects IgG
Doorn, P.A. (Pieter) van +6 more
core +1 more source
Introduction. The heterogeneity of the forms and severity of Guillain-Barre syndrome explains the variability of recovery: from rapid and complete (in most cases) to slow with the development of persistent residual deficiency (rarely).
D. A. Grishina, N. A. Suponeva
doaj +1 more source
In Finland a vaccination programme against human papillomavirus (HPV) was introduced in November 2013 for girls aged 11-12 years with a catchup for girls 13-15 years. Allegations that HPV vaccine is causing Guillain Barré syndrome (GBS) and non-specific diagnostic entities, such as chronic fatigue syndrome/systemic exertion intolerance disease (CFS ...
J. Skufca +4 more
openaire +3 more sources
Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia [PDF]
Background: A number of Zika vaccine platforms are currently being investigated, some of which have entered clinical trials. We sought to evaluate the cost-effectiveness of a potential Zika vaccine candidate under the WHO Vaccine Target Product Profile ...
Moghadas, Seyed +2 more
core +2 more sources
Guillain–Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report
Guillain–Barré syndrome is characterized by progressive motor weakness, sensory changes, dysautonomia, and areflexia. Cranial nerve palsies are frequent in Guillain–Barré syndrome.
Kamal Sharma +4 more
doaj +1 more source
A rare clinical presentation of Ebstein-Barr virus
In this letter we report a case of Guillain-Barré syndrome associated with infectious mononucleosis. A 20-year-old woman presented to our hospital with weakness of legs and arms.
Çagatay Öncel
doaj +1 more source

